Literature DB >> 3124710

Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis. Committee on Health Care Issues, American Neurological Association.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3124710     DOI： 10.1002/ana.410220416

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  2 in total

1.  Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.

Authors:  P G Chiodini; R Attanasio; A Liuzzi; R Cozzi; P Orlandi; C De Palo; D Dallabonzana; F Girotti; D Testa
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

2.  Amyotrophic lateral sclerosis: thyroid and prolactin hormone changes in thyrotropin-releasing hormone therapy.

Authors:  D Testa; P G Chiodini; F Girotti; R Attanasio
Journal:  Ital J Neurol Sci       Date:  1990-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.